Yumiko Uno Selected Research

benzofuran

12/2011

A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yumiko Uno Research Topics

Disease

2	Alzheimer Disease (Alzheimer's Disease) 12/2011 - 10/2009
1	Hemolysis 01/2021
1	Huntington Disease (Huntington's Disease) 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 04/2012
1	Atherosclerosis 04/2012
1	Amyloid Plaque 12/2011
1	Disease Progression 11/2009
1	Tauopathies 11/2009

Drug/Important Bio-Agent (IBA)

2	Glycogen Synthase Kinase 3IBA 12/2011 - 11/2009
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2021
1	Cytidine Monophosphate N-Acetylneuraminic AcidIBA 01/2021
1	Blood Group Antigens (Blood Groups)IBA 01/2021
1	Nucleocytoplasmic Transport ProteinsIBA 01/2021
1	25-hydroxycholesterolIBA 04/2012
1	cholesterol 25-hydroxylaseIBA 04/2012
1	Carbon MonoxideIBA 04/2012
1	CholesterolIBA 04/2012
1	EnzymesIBA 04/2012
1	benzofuranIBA 12/2011
1	Glycogen Synthase (Synthase I)IBA 12/2011
1	Amyloid (Amyloid Fibrils)IBA 12/2011
1	OxadiazolesIBA 12/2011
1	Glycogen Synthase KinasesIBA 10/2009